Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 5, 2013, Pages 492-497

  Turner, Dan ^a   Wolters, Victorien M ^b   Russell, Richard K ^c   Shakhnovich, Valentina ^d   Muise, Aleixo M ^e   Ledder, Oren ^a   Ngan, Bo ^e   Friesen, Craig ^d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d Mercy Hospital   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Adalimumab; Anti TNF antibodies; Eosinophilic colitis; Eosinophilic enteritis; Eosinophilic enterocolitis; Infliximab

Indexed keywords

ADALIMUMAB; ALBENDAZOLE; ALPRAZOLAM; AMITRIPTYLINE; BUDESONIDE; CALGRANULIN; CETIRIZINE; CODEINE; CROMOGLYCATE DISODIUM; CYPROHEPTADINE; FENTANYL; GABAPENTIN; HYDROXYZINE; INFLIXIMAB; KETOTIFEN; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; MONTELUKAST; OMEPRAZOLE; OXYCODONE; PARACETAMOL; PAROXETINE; PREDNISONE; RANITIDINE; STEROID; TRAMADOL;

ABDOMINAL PAIN; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; CAPSULE ENDOSCOPY; CATCH UP GROWTH; CHILD; CLINICAL ARTICLE; COGNITIVE THERAPY; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; CORTICOSTEROID THERAPY; CROHN DISEASE; DEPRESSION; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE INTENSIFICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DUODENUM BIOPSY; ELEMENTAL DIET; ENDOSCOPIC BIOPSY; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC COLITIS; EOSINOPHILIC ENTERITIS; EPIGASTRIC PAIN; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; FEMALE; HEARTBURN; HEMATEMESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; INFANT; INFLAMMATORY INFILTRATE; INTESTINE VILLUS ATROPHY; LAMINA PROPRIA; LOOSE FECES; MALE; POSTTRAUMATIC STRESS DISORDER; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; PSYCHOTHERAPY; RELAXATION TRAINING; REMISSION; REPEAT PROCEDURE; SATIETY; SCHOOL CHILD; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; VOMITING;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD; CHILD, PRESCHOOL; ENDOSCOPY; ENTEROCOLITIS; EOSINOPHILIA; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; REMISSION INDUCTION; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877043227     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182801e60     Document Type: Article

References (32)

1. Noel RJ, Rothenberg ME. Eosinophilic esophagitis. Curr Opin Pediatr 2005;17:690-4
2. Straumann A, Simon HU. Eosinophilic esophagitis: Escalating epidemiology? J Allergy Clin Immunol 2005;115:418-9
3. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113:11-28
4. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342-63
5. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:3-20
6. Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: An update on pathophysiology and treatment. Br Med Bull 2011;100:59-72
7. Khan S, Orenstein SR. Eosinophilic gastroenteritis: Epidemiology, diagnosis and management. Paediatr Drugs 2002;4:563-70
8. Yan BM, Shaffer EA. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009;58:721-32
9. Katsanos KH, Zinovieva E, Lambri E, et al. Eosinophilic-Crohn overlap colitis and review of the literature. J Crohns Colitis 2011;5:256-61
10. Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroidsparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci 2001;46:1787-90
11. Melamed I, Feanny SJ, Sherman PM, et al. Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med 1991;90:310-4
12. Perez-Millan A, Martin-Lorente JL, Lopez-Morante A, et al. Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate. Dig Dis Sci 1997;42:342-4
13. Di Gioacchino M, Pizzicannella G, Fini N, et al. Sodium cromoglycate in the treatment of eosinophilic gastroenteritis. Allergy 1990;45:161-6
14. Lee CM, Changchien CS, Chen PC, et al. Eosinophilic gastroenteritis: 10 years experience. Am J Gastroenterol 1993;88:70-4
15. Redondo-Cerezo E, Cabello MJ, Gonzalez Y, et al. Eosinophilic gastroenteritis: Our recent experience: One-year experience of atypical onset of an uncommon disease. Scand J Gastroenterol 2001;36:1358-60
16. Pache I, Rogler G, Felley C. TNF-Alpha blockers in inflammatory bowel diseases: Practical consensus recommendations and a user's guide. Swiss Med Wkly 2009;139:278-87
17. Temkin V, Levi-Schaffer F. Mechanism of tumour necrosis factor alpha mediated eosinophil survival. Cytokine 2001;15:20-6
18. Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-Type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954-61
19. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536-47
20. Straumann A, Bussmann C, Conus S, et al. Anti-TNF-Alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol 2008;122:425-7
21. Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: A randomised, placebo-controlled, double-blind trial. Gut 2010;59:21-30
22. Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2012; 129:456-63
23. Behjati S, Zilbauer M, Heuschkel R, et al. Defining eosinophilic colitis in children: Insights from a retrospective case series. J Pediatr Gastroenterol Nutr 2009;49:208-15
24. Klein NC, Hargrove RL, Sleisenger MH, et al. Eosinophilic gastroenteritis. Medicine (Baltimore) 1970;49:299-319
25. Whitington PF, Whitington GL. Eosinophilic gastroenteropathy in childhood. J Pediatr Gastroenterol Nutr 1988;7:379-85
26. Naylor AR. Eosinophilic gastroenteritis. Scott Med J 1990;35:163-5
27. Ngo P, Furuta G, Burks W. The pathobiology of eosinophilic gastroenteritis of childhood: Is it really the eosinophil, allergic mediated, or something else? Curr Gastroenterol Rep 2004;6:436-40
28. Bohm M, Richter JE. Treatment of eosinophilic esophagitis: Overview, current limitations, and future direction. Am J Gastroenterol 2008; 103:2635-44
29. Magnusson J, Lin XP, Dahlman-Hoglund A, et al. Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy Clin Immunol 2003;112:45-50
30. Uzunismail H, Hatemi I, Dogusoy G, et al. Dense eosinophilic infiltration of the mucosa preceding ulcerative colitis and mimicking eosinophilic colitis: Report of two cases. Turk J Gastroenterol 2006;17:53-7
31. Furuta GT, Forbes D, Boey C, et al. Eosinophilic gastrointestinal diseases (EGIDs). J Pediatr Gastroenterol Nutr 2008;47:234-8
32. Forbes E, Hulett M, Ahrens R, et al. ICAM-1-dependent pathways regulate colonic eosinophilic inflammation. J Leukoc Biol 2006; 80:330-41